 |
Fact Sheet: Medicare Part B Coverage of Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention
CMS.gov | September 30, 2024
|
|
Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia
BMC Infectious Diseases - BioMed Central | September 28, 2024
|
|
Long-acting injectable lenacapavir continues to show promising results for HIV prevention
World Health Organization (WHO) | September 26, 2024
|
|
Drug-Related Problems in HIV Treatment Failure
Cureus | September 21, 2024
|
|
New two-dose HIV vaccine strategy shows promise for stronger immune response
News Medical | September 20, 2024
|
|
Medicaid must prepare to cover twice-yearly HIV prevention injection
STAT | September 19, 2024
|
|
This preventive drug could be a 'game changer' in ending the HIV epidemic
NPR | September 17, 2024
|
|
Type 2 Diabetes Drug Metformin May Help Reduce Viral Reservoir in People with HIV
Healthline | September 16, 2024
|
|
The Significance of Antimicrobial Stewardship in Dentistry
Contagion Live | September 9, 2024
|
|
HIV antiretroviral therapy saves over a million lives each year
Our World in Data | September 2024
|
|
Investors can play 'pivotal role' in addressing antimicrobial resistance, report says
CIDRAP | August 30, 2024
|
|
Breakthrough HIV drug Lenacapavir Shows promising results in recent study
FOX5 | August 16, 2024
|
|
Reproductive-Aged Women With HIV Express Interest in Long-Acting ART Options
IDA | August 15, 2024
|
|
Sussex launches new online HIV medication service
BBC | August 11, 2024
|
|
Dovato (dolutegravir/lamivudine) - Uses, Side Effects, and More
WebMD | August 11, 2024
|
|
Doctor behind trial of HIV prevention drug recounts breakthrough moment
The Guardian | July 26, 2024
|
|
With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift
Managed Healthcare | July 25, 2024
|
|
Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning’
AP | July 24, 2024
|
|
What is an Investigational HIV Drug?
NIH | July 23, 2024
|
|
HIV drug could be made for just $40 a year for every patient
The Guardian | July 23, 2024
|
|
CDC Releases Antimicrobial Resistant Threats Data From During 2021-2022
CDC | July 16, 2024
|
|
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1
AACP Journals | July 15, 2024
|
|
ViiV Healthcare To Announce Data From Largest Head-To-Head Randomised Clinical Trial For 2-Drug Regimen Dovato Against 3-Drug...
ViiV Healthcare | July 15, 2024
|
|
Biden administration appeals jury finding in battle over patents for HIV prevention pills
STAT | July 8, 2024
|
|
Presentation: Implementation of Long-Acting Drugs for the Treatment and Prevention of HIV
IAS | July 23, 2034
|
|
A new way to prevent HIV delivers dramatic results in trial: PURPOSE 1
KRWG | July 3, 2024
|
|
Although No-Cost Prep Is Safe For Now, Ruling Still Leaves Free Preventive Care At Risk
AAHIVM | June 27, 2024
|
|
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters | June 20, 2024
|
|
Long-Acting Oral Combo for HIV Maintains Viral Suppression at Week 24
IDSE | June 15, 2024
|
|
Two-Drug Dolutegravir-Based Antiretroviral Therapy Supported for HIV Management
Infectious Disease Advisor | June 12, 2024
|
|
NIH launches two clinical trials on long-acting HIV PrEP
PharmaNews | June 7, 2024
|
|
Dr. Mermin Discusses New Doxy PEP Guidelines for STI Prevention
HIV.gov | June 6, 2024
|
|
CDC Publishes Doxy PEP Clinical Guidelines for Bacterial STI Prevention
HIV.gov | June 4, 2024
|
|
Pharma firm urged to share new 'game-changer' HIV drug
Medical Xpress | May 30, 2024
|
| |
|
|
|
HIV Preexposure Prophylaxis (PrEP)
National HIV Curriculum | May 6, 2024
|
|
Feasibility of Implementing a Low-Barrier Long-Acting Injectable Antiretroviral Program for HIV Treatment and Prevention for People...
NIH | May 1, 2024
|
|
Caution advised when prescribing long-acting injectable cabotegravir and rilpivirine to avoid drug resistance
Aidsmap | April 30, 2024
|
|
FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
GILEAD | April 26, 2024
|
|
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
The New York Times | April 17, 2024
|
|
More evidence that PrEP works as well for women
Aidsmap | April 17, 2024
|
|
Considerations for Implementing Cabotegravir (Apretude) as PrEP for HIV Infection
AAFP | April 2024
|
|
FDA Approves Dovato for Teens Living With HIV
Drugs.com | April 10, 2024
|
|
FDA approves dolutegravir/lamivudine to treat HIV infection in adolescents
Contemporary Pediatrics | April 8, 2024
|
|
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons...
Oxford Academic - Oxford University Press | April 6, 2024
|
|
Understanding HIV drug resistance, implications for treatment strategies
PharmaNewsIntelligence | March 25, 2024
|
|
Many Americans Are Unaware of HIV Prevention Medication
KFF | March 20, 2024
|
|
New drug candidates show promise to reverse HIV immune evasion
News Medical | March 19, 2024
|
|
U.S. FDA Approves EDURANT® PED (rilpivirine) for Certain Pediatric Patients Living with HIV-1
Johnson & Johnson | March 19, 2024
|
|
HIV Medications 101
AETC | March 19, 2024
|
|
People who struggle with daily HIV regimen should be offered long-acting injections
Healio | CROI 2024 | March 9, 2024
|
|
Investigational two-drug regimen safe, effective for patients with HIV
Healio | CROI2024 | March 6, 2024
|
|
PrEP use up, HIV incidence down, data show
Healio | CROI2024 | March 5, 2024
|
|
Dolutegravir-Based ART Efficacious for HIV Management Through 192 Weeks
Infectious Disease Advisor | March 13, 2024
|
|
Semaglutide Reduces Liver Fat in People Living With HIV
POZ | March 13, 2024
|
|
Ultra-Long-Acting Cabotegravir Could Be Given Every Four Months
POZ | March 11, 2024
|
|
New treatment options for critically important WHO fungal priority pathogens
Clin Microbiol Infect. 2024 Mar 8:S1198-743X(24)00118-6. doi: 10.1016/j.cmi.2024.03.006
|
|
Examining a Newer Therapy for Heavily Treated HIV Patients
Contagion Live | March 7, 2024
|
|
Gilead’s Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health
Gilead | March 5, 2024
|
|
New report documents increase in HIV drug resistance to dolutegravir
WHO | March 5, 2024
|
|
New HIV Drugs on the Horizon (webinar)
IAS-USA | February 19, 2024
|
|
Antiretroviral Medications and Initial Therapy
National HIV Curriculum | February 11, 2024
|
|
2024 Session: Florida may allow pharmacists to prescribe HIV prevention drugs
Tallahassee Democrat | February 9, 2024
|
|
Do Higher PrEP Costs Affect Risk for Subsequent HIV Infection?
NEJM | January 29, 2024
|
|
How Does Smoking Affect People with HIV?
HIV.gov | January 26, 2024
|
|
Enhancing quality of life and medication adherence for people living with HIV: the impact of an information system
NIH | January 23, 2024
|
|
New Antibiotic Effective Against Drug-Resistant Bacteria, Study Indicates
CNN | January 3, 2024
|
| |
|
|
